MicroMGx
Discovery platform to identify hundreds of new compounds
Overview
Raised: $124,508
Rolling Commitments ($USD)
04/29/2023
$546
2015
Business Services, Software, & Applications
Biotech
B2B
Medium
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$523,700 |
$537,000 |
COGS |
$731,195 |
$724,353 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-134,068 |
$-269,672 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$85,011 |
$203,237 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$208,505 |
$221,539 |
Short-Term Debt |
$86,000 |
$0 |
Long-Term Debt |
$160,300 |
$117,200 |
Total Liabilities |
$246,300 |
$117,200 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual